Search results
Showing 16 to 30 of 105 results for psychosis
Smoking: smoking status of people with bipolar, schizophrenia and other psychoses (IND154)
This indicator covers the percentage of patients with schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM124
with psychosis and schizophrenia:- What is the benefit of a CBT-based trauma reprocessing intervention on PTSD symptoms in people with...
This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.
This indicator covers the percentage of patients aged between 25 and 84 years with schizophrenia, bipolar affective disorder and other psychoses (excluding those with pre-existing cardiovascular disease, chronic kidney disease, familial hypercholesterolaemia or type 1 diabetes) who have had a full formal cardiovascular disease risk assessment performed in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM120
Mental health is one of the key clinical areas of health inequalities identified in NHS England’s Core20PLUS5 framework for children and young people.
Bipolar, schizophrenia and other psychoses: cervical screening (IND85)
This indicator covers the percentage of women aged 25 or over and who have not attained the age of 65 with schizophrenia, bipolar affective disorder and other psychoses whose notes record that a cervical screening test has been performed in the preceding 5 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM20
interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with...
interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with...
benefits of early intervention in psychosis services after discharge:- How can the benefits of early intervention in...
at high risk of postpartum psychosis and reduce this risk? Any explanatory notes(if applicable) Postpartum psychosis is a...
coexisting physical health conditions on the mortality of people with complex psychosis? Any explanatory notes(if applicable) Assessment...
attenuated or transient psychotic symptoms suggestive of a developing psychosis, and can the criteria for 'at risk states' be refined to...
This guideline covers preventing, assessing and managing mental health problems in people with learning disabilities in all settings (including health, social care, education, and forensic and criminal justice). It aims to improve assessment and support for mental health conditions, and help people with learning disabilities and their families and carers to be involved in their care.
What risk factors predict the onset of substance misuse in young people with psychosis?
risk factors predict the onset of substance misuse in young people with psychosis? Any explanatory notes(if applicable) None. Source...
children and young people considered to be at high risk of developing psychosis? Any explanatory notes(if applicable) The suggested...